93
|
fluidigm
ccr4 Ccr4, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/l291h4/pmc12108741-27-0-6?v=fluidigm Average 93 stars, based on 1 article reviews
ccr4 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
94
|
fluidigm
anti cd194 ccr4 175lu  Anti Cd194 Ccr4 175lu, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/l291h4/pmc06348010-87-0-3?v=fluidigm Average 94 stars, based on 1 article reviews
anti cd194 ccr4 175lu - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
92
|
fluidigm
3158032a  3158032a, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/l291h4/pmc08561238-12-6-3?v=fluidigm Average 92 stars, based on 1 article reviews
3158032a - by Bioz Stars,
2026-07
92/100 stars
|
Buy from Supplier |
N/A
|
CD194, also known as CC chemokine receptor 4 (CCR4), belongs to the G protein-coupled receptor family. It is expressed on stimulated and unstimulated T and B cells, basophils, monocytes, and NK cells. Human peripheral blood
|
Buy from Supplier |
N/A
|
CD194, also known as CC chemokine receptor 4 (CCR4), belongs to the G protein-coupled receptor family. It is expressed on stimulated and unstimulated T and B cells, basophils, monocytes, and NK cells. Human peripheral blood
|
Buy from Supplier |
Image Search Results
Journal: Cell
Article Title: Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
doi: 10.1016/j.cell.2018.05.060
Figure Lengend Snippet: KEY RESOURCES TABLE
Article Snippet:
Techniques: Staining, Antibody Labeling, Software, Diffusion-based Assay
Journal: Cell Reports Medicine
Article Title: Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma
doi: 10.1016/j.xcrm.2021.100411
Figure Lengend Snippet:
Article Snippet: CCR4 (L291H4) ,
Techniques: Recombinant, Isolation, Mass Cytometry, Software